IL10 rs3024547: Exploring Allergic Sensitization
rs3024547 is a noncoding upstream regulatory single-nucleotide polymorphism located adjacent to the human IL10 gene. Research suggests it may influence interleukin-10 cytokine production and exhibits statistical associations with variations in allergic sensitization and inflammatory traits. The overall evidence supporting direct individual health effects remains limited, reflecting complex, multi-gene immune regulation.
What each genotype means
Typical IL10 regulatory profile
This genotype represents the common regulatory configuration for the IL10 gene. Research suggests this variant may influence the production of anti-inflammatory cytokines, though its specific impact on allergic sensitization remains a subject of ongoing study with limited evidence.
Carried by approximately 49% of individuals in populations where the minor allele frequency is 0.30.
Intermediate IL10 regulatory profile
Carrying one copy of the minor allele may subtly modulate the expression of IL10, a key cytokine involved in immune regulation. Current evidence is limited regarding how this specific genotype influences individual risk for allergic conditions, and it should not be used to predict clinical outcomes.
Carried by approximately 42% of individuals in populations where the minor allele frequency is 0.30.
Variant IL10 regulatory profile
This genotype involves two copies of the minor allele, which has been investigated for its potential role in altering anti-inflammatory cytokine pathways. While linked to allergic sensitization in some research contexts, the evidence remains limited and the clinical significance for any individual is not well-established.
Carried by approximately 9% of individuals in populations where the minor allele frequency is 0.30.
Genomic Location and Regulatory Role
The single-nucleotide polymorphism rs3024547 is situated in the 5-prime upstream flanking region of the IL10 gene on chromosome 1. Rather than altering a protein coding sequence directly, this noncoding variation is located within putative transcriptional regulatory machinery. Genetic variants in such upstream regions frequently act by altering transcription factor binding motifs, modifying chromatin accessibility, or influencing enhancer-promoter communication. Data cataloged in repositories such as dbSNP and Ensembl position rs3024547 within a haplotype block encompassing several immune regulatory elements. Because it resides in a noncoding intergenic or promoter-adjacent stretch, scientists study it primarily to understand whether distinct alleles alter baseline or stimulated transcription rates of neighboring immunomodulatory genes.
Biological Function of the IL10 Gene
The IL10 gene encodes interleukin-10, an indispensable anti-inflammatory cytokine produced by diverse immune cell subsets, including regulatory T cells, macrophages, and B cells. Interleukin-10 plays a critical role in preserving immune homeostasis by inhibiting the excessive synthesis of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-12. In allergic biology, interleukin-10 suppresses allergen-induced eosinophil activation, limits airway hyperresponsiveness, and curbs mast cell degranulation. Dysregulation of IL-10 signaling has been implicated across a wide spectrum of human immune-mediated phenotypes, including inflammatory bowel diseases, asthma, and severe atopic diatheses, highlighting the delicate balance required to modulate inflammation without compromising pathogen clearance.
Association Research and Strength of Evidence
Population association studies have examined rs3024547 for correlations with immune traits, primarily allergic sensitization, asthma vulnerability, and broader inflammatory conditions. Certain investigative cohorts have observed statistically significant shifts in allergen-specific immunoglobulin E (IgE) levels or total sensitization risk among carriers of specific alleles. However, the overall strength of clinical and epidemiological evidence remains limited. Many reported associations are modest, displaying small odds ratios, and results frequently vary between study cohorts due to differing environmental exposures, allergen panels, or population stratification. Consequently, while rs3024547 serves as an intriguing biological candidate marker in immunogenomics research, it is not established as a high-penetrance determinant of allergic diseases.
Population Frequency and Ancestral Diversity
According to large-scale global population sequencing and cohort aggregations such as dbSNP and gnomAD, rs3024547 is a common bi-allelic variant. The minor allele frequency hovers near approximately 0.30 across European and East Asian cohorts, meaning that a substantial portion of individuals in these groups carry at least one copy. Significant variations in background allele frequencies and linkage disequilibrium architecture exist across diverse ancestries, including African and Indigenous American populations. Because allele frequencies and co-inherited surrounding variants differ globally, an association discovered in one ancestral background cannot be assumed to impart identical statistical effects in another without careful local replication.
Clinical Utility: What This Information Means for You
Understanding your rs3024547 genotype provides educational insight into one small component of your immune system's genetic architecture, but it has no stand-alone diagnostic utility. Having an associated genotype does not mean you have an allergy, nor does it guarantee that you will develop allergic sensitization in the future. Allergic disorders are classical complex conditions governed by hundreds of genomic loci interacting dynamically with environmental triggers, early microbial exposures, and lifestyle factors. Genetic findings of this nature must never replace formal medical evaluation. If you suffer from allergic symptoms or suspected sensitivities, diagnostic testing such as skin-prick evaluations and IgE panels should be interpreted alongside an experienced allergist or clinical physician.
How common is this variant?
The minor allele occurs at an estimated frequency of approximately 0.30 in European and East Asian populations, making all three genotype combinations relatively common across these ancestral groups.
Frequently asked questions
Does having the rs3024547 variant mean I will develop allergies?
No, having an associated allele at rs3024547 does not diagnose or predict an inevitable allergy. Allergic disorders are complex traits driven by hundreds of low-effect genetic markers combined with environmental factors, allergens, and lifestyle elements.
What is the primary function of the IL10 gene?
IL10 encodes interleukin-10, an essential anti-inflammatory cytokine that calms immune activity. It prevents excessive tissue damage by downregulating inflammatory signals and regulating immune cell responses during an infection or allergic trigger.
Can rs3024547 results guide allergy medications or treatments?
No, there are currently no pharmacogenomic guidelines or clinical treatments tailored around rs3024547 genotype status. Any concerns regarding allergic symptoms, immunotherapies, or prescription dosing should always be addressed directly with your qualified healthcare provider.
Why do different scientific studies report conflicting findings for this variant?
Genetic association studies often yield varying results due to differences in sample size, ancestral linkage disequilibrium, and unique environmental exposures among participants. Because rs3024547 exerts only a subtle regulatory influence, its measurable effects can be masked or amplified by surrounding contextual factors.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3024547?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL10
The IL-10 promoter -819C/T polymorphism modulates interleukin-10 expression, influencing inflammatory responses and autoimmune susceptibility.
The -592C/A variant in the promoter of IL-10 regulates transcription factor binding, impacting cytokine output and risk for inflammatory bowel disease.
Part of the extended IL-10 promoter haplotype influencing differential anti-inflammatory IL-10 cytokine output and susceptibility to graft-versus-host disease.
Functional promoter variant (-1082 A/G) influencing interleukin-10 expression levels and inflammatory disease susceptibility.
Functional regulatory promoter variant in IL10 associated with altered interleukin-10 expression and enhanced susceptibility to dust mite allergic sensitization.
Variant in the interleukin-10 gene interacting with environmental dust mite exposure to significantly alter the risk of allergic sensitization and exacerbations.